Cargando…
New treatments for hyperkalaemia: clinical use in cardiology
Hyperkalaemia causes significant burden, and even mild hyperkalaemia has been independently associated with increased morbidity and mortality. Patients with chronic disease states, such as heart failure, hypertension, chronic kidney disease and diabetes mellitus, are increasingly susceptible to the...
Autores principales: | Vijayakumar, Shilpa, Butler, Javed, Anker, Stefan D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392415/ https://www.ncbi.nlm.nih.gov/pubmed/30837804 http://dx.doi.org/10.1093/eurheartj/suy031 |
Ejemplares similares
-
Barriers to guideline mandated renin–angiotensin inhibitor use: focus on hyperkalaemia
por: Vijayakumar, Shilpa, et al.
Publicado: (2019) -
Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
por: Rosano, Giuseppe M C, et al.
Publicado: (2019) -
Hyperkalaemia: aetiology, epidemiology, and clinical significance
por: Tromp, Jasper, et al.
Publicado: (2019) -
A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrology
por: Rossignol, Patrick
Publicado: (2019) -
Management of hyperkalaemia in adults.
por: McVeigh, G.
Publicado: (2005)